Trial Profile
An Open-Label, Single-Arm, Phase I Study of Troxatyl (Troxacitabine) Administered by Continuous Infusion in Subjects With an Advanced Solid Malignancy
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2006
Price :
$35
*
At a glance
- Drugs Troxacitabine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 07 Nov 2006 Status change
- 06 Sep 2005 New trial record.